文献速递胰腺与胆道疾病消化内镜

LAMS与防移位管状SEMS用于EUS引导胆囊引流的疗效与安全性比较

Comparison of the effectiveness and safety of lumen-apposing metal stents and anti-migrating tubular self-expandable metal stents for EUS-guided gallbladder drainage in high surgical risk patients with acute cholecystitis.
PubMed 文献 · Gastrointest Endosc · 2019-10-17

该回顾性队列研究分析了2015至2017年间71例高手术风险急性胆囊炎患者,比较LAMS与ATSEMS行EUS-GBD的效果。

要点

  • LAMS与ATSEMS行EUS-GBD的技术和临床成功率均高且相似。
  • 两组不良事件及6、12个月胆囊炎复发率无显著差异。
  • LAMS组中位手术时间显著长于ATSEMS组(15.5 vs 11分钟)。

核心结论

  • 在高手术风险急性胆囊炎患者中,LAMS与ATSEMS行EUS-GBD的技术成功率、临床成功率、操作相关不良事件、支架相关晚期不良事件及胆囊炎复发率均相似。

研究设计与样本

  • 回顾性分析前瞻性收集的EUS-GBD数据库,纳入2015年1月至2017年12月间连续接受LAMS或ATSEMS行EUS-GBD的急性胆囊炎患者共71例(LAMS组36例,ATSEMS组35例)。

临床怎么用

  • 对于高手术风险急性胆囊炎患者,LAMS与ATSEMS均可作为EUS-GBD的支架选择,两者疗效与安全性相似。
  • LAMS手术时间较长,临床选择时需权衡操作效率与支架特性。

局限性

  • 回顾性研究设计,样本量较小(共71例),可能影响统计效能。
  • 数据来自两家医院,外推性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) using an anti-migrating tubular self-expandable metal stent (ATSEMS) is performed in high surgical risk patients with acute cholecystitis. The newly introduced lumen-apposing metal stent (LAMS) is expected to reduce the risk of tubular self-expandable metal stent-related adverse events such as stent migration, but no comparative studies have been carried out between LAMSs and ATSEMSs for EUS-GBD. METHODS: We reviewed the prospectively collected EUS-GBD database at Asan Medical Center and Bucheon Soonchunhyang hospital to analyze consecutive patients with acute cholecystitis who underwent EUS-GBD with LAMSs or ATSEMSs between January 2015 and December 2017. Technical success, clinical success, adverse events, and recurrence of cholecystitis were evaluated. RESULTS: A total of 71 patients (36 with LAMSs, 35 with ATSEMSs) were analyzed. The LAMS group had longer median procedure time (15.5 minutes) than the ATSEMS group (11 minutes; P = .017). The 2 groups did not show significant differences in terms of technical success (LAMS, 94% vs ATSEMS, 100%; P = .49), clinical success (94% vs 100%; P = .49), procedure-related adverse events (0% vs 2.9%; P = .99), and stent-related late adverse events (11.8% vs 5.8%; P = .43). During follow-up, the 2 groups had similar rates of cholecystitis recurrence at 6 months (LAMS, 3.4% vs ATSEMS, 3.1%, P = .99) and 12 months (8.3% vs 3.1%, P = .56). CONCLUSIONS: In high surgical risk patients with acute cholecystitis, LAMSs and ATSEMSs for EUS-GBD showed similar rates of technical success, clinical success, procedure-related adverse events, stent-related late adverse events, and recurrence of cholecystitis.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Cho SH, Oh D, Song TJ, et al. Comparison of the effectiveness and safety of lumen-apposing metal stents and anti-migrating tubular self-expandable metal stents for EUS-guided gallbladder drainage in high surgical risk patients with acute cholecystitis. Gastrointest Endosc. 2019. PMID: 31629721. doi:10.1016/j.gie.2019.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。